Suicidality in children and adolescents being treated with antidepressant medications

FDA Public Health Advisory announcing a multi-pronged strategy to warn the public about the increased risk of suicidal thoughts and behavior (“suicidality”) in children and adolescents being treated with antidepressant medications.

See This Resource

Author: U.S. Food and Drug Administration (FDA)

Year Published/Updated: 2004

Resource Type: Guidelines/Recommendations